Unknown PHASE4 INTERVENTIONAL 2-arm NCT03017391

Treatment Algorithm for Nausea and Vomiting in the Palliative Phase

Feasibility Study to Compare 2 Strategies of Treatment Algorithm for Treating Nausea and or Vomiting in the Palliative Phase of Cancer Care

Sponsor: Radboud University Medical Center

Conditions Cancer Nausea Vomiting

Interventions Dexamethasone Granisetron 2Mg Tablet granisetron metoclopramide

Updated 7 times since 2017 Last updated: Jan 9, 2017 Started: Jan 31, 2017 Primary completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cancer and Nausea and is currently ongoing. Radboud University Medical Center leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Mar 2022 [monthly]

Unknown Status PHASE4
Jan 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jan 2019 [monthly]

Not Yet Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Radboud University Medical Center

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.